CGON CG Oncology, Inc. Common stock
$69.18
▲ 1.72%
39
Value
13
P/E-33.22
8
P/B7.11
43
P/S1445.85
0
EV/EBITDA-34.76
5
Growth
62
Revenue Growth254.7%
100
EPS Growth-47.5%
40
FCF Growth-67.8%
37
Momentum
79
12-Month Return218.8%
100
3-Month Return40.6%
100
1-Month Return0.5%
54
RSI (14)38.19
50
50/200 MABullish
75
Profitability
11
ROE-22.9%
47
ROA-20.3%
0
Gross Margin-15.0%
5
Operating Margin-4722.1%
0
Net Margin-3985.0%
0
FCF Yield-2.3%
0
Risk
25
Beta0.42
55
60-Day Volatility43.8%
0
QScore Analysis